作者: Siamak Daneshmand , Christie J. Moore , Craig R. Nichols , Do , G. Varuni Kondagunta
DOI:
关键词:
摘要: Although testicular cancer is a rare disease accounting for only 1% of all male neoplasms, it represents paradigm curability. Overall, more than 95% patients can expect to be cured their with minimal long-term toxicity. Given these expectations, critical that care providers are familiar the diagnostic and therapeutic challenges encountered in patients. In particular, clinicians managing should aware some pitfalls when determining relapse. series case presentations, we review evaluation management persistent elevation serum tumor markers postchemotherapy residual radiographic abnormalities.